The authors demonstrate a strategy to rapidly link Alzheimer's disease (AD) risk genes to druggable biological processes using zebrafish. They first identified that around 75% of human AD risk genes have clear orthologues in zebrafish, and most are expressed early in larval brain development.
The authors then developed a high-throughput video-tracking system and analysis pipeline (FramebyFrame) to measure sleep/wake behaviors of zebrafish larvae with F0 knockouts of AD risk genes at high temporal resolution. This revealed distinct behavioral phenotypes for different gene knockouts:
The authors suggest these behavioral changes reflect disruption of specific biological processes that contribute to AD pathogenesis. As proof-of-concept, they showed that sorl1 mutants have disrupted serotonin signaling, and identified betamethasone as a drug that can normalize the sleep phenotype of presenilin-2 knockouts.
This behavioral pharmacology approach provides a general framework to rapidly link disease-associated genes to druggable pathways, which could accelerate the discovery of new therapeutic targets.
Sang ngôn ngữ khác
từ nội dung nguồn
biorxiv.org
Thông tin chi tiết chính được chắt lọc từ
by Krol... lúc www.biorxiv.org 11-29-2023
https://www.biorxiv.org/content/10.1101/2023.11.28.568940v1Yêu cầu sâu hơn